Community-Acquired Pneumonia
Community-acquired pneumonia (CAP) is a disease associated with high morbidity and mortality, with at least one third of cases requiring hospitalization, exceeding the numbers admitted for myocardial infarction and stroke. Despite a broad armamentarium of antimicrobials available, it remains an impo...
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Birkhäuser Basel,
2007.
|
| Series: | Birkhäuser Advances in Infectious Diseases
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
Table of Contents:
- Diagnosis and treatment of community acquired pneumonia - the German perspective
- Detection of respiratory bacterial pathogens
- Viral pathogens and epidemiology, detection, therapy and resistance
- Resistance in Streptococcus pneumoniae
- Influenza
- Pathogenesis of Chlamydophila pneumoniae infections — epidemiology, immunity, cell biology, virulence factors
- Legionnaires’ disease and its agent Legionella pneumophila
- Pathogenesis of Streptococcus pneumoniae infections:adaptive immunity, innate immunity, cell biology, virulence factors
- Pathogenesis of Mycoplasma pneumoniae infections:adaptive immunity, innate immunity, cell biology, and virulence factors
- Community-acquired pneumonia: paving the way towards new vaccination concepts.